Skip to main content

Advertisement

SpringerLink
Log in

Genetic polymorphisms in oestrogen metabolic pathway and breast cancer: a positive association with combined CYP/GST genotypes

  • Original
  • Published:
Clinical and Experimental Medicine Aims and scope Submit manuscript

Abstract

The cytochrome P450 family (CYPs) and the glutathione S-transferase (GSTs) enzymes play an important role in the metabolism of environmental carcinogens and of oestrogen and can affect breast cancer risk. In this study we examine the role of the genes CYP1A1, CYP17, CYP2D6, GSTM1, GSTP1 and GSTT1 in breast cancer risk in Brazilian women. The study population consisted of 102 incident breast cancer cases and 102 healthy controls. Genotyping analyses were performed by PCR-based methods. A significant finding was observed between GSTP1 Ile-Val polymorphism and breast cancer risk (OR = 1.81; CI 95% = 1.04–3.16). A significant association was observed between women with 0–2 risk genotypes and those with 4 or more risk genotypes (OR = 2.42; CI 95% = 1.13–5.18) when the potential combined effects of the risk genotypes were examined. No significant differences between cases and controls were found correlating the genotypes and the clinical-histopathological parameters. In conclusion, in our population only GSTP1 was associated with breast cancer risk. However, when the genes were tested in combination, a significant association in the breast cancer risk was observed.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. INCA/MS, Instituto Nacional de Câncer do Ministério da Saúde (2007) http://www.inca.org.br. Accessed July 2007

  2. Yager JD (2000) Endogenous estrogens as carcinogens through metabolic activation. J Nat Cancer Inst Monographs 27:67–73

    CAS  Google Scholar 

  3. Nebert DW, Mckinnon RA, Puga A (1996) Human-drug metabolizing enzyme polymorphisms: effects on risk of toxicity and cancer. DNA Cell Biol 15:273–280

    Article  PubMed  CAS  Google Scholar 

  4. Han W, Kang D, Park, IA et al (2004) Associations between breast cancer susceptibility gene polymorphisms and clinicopathological features. Clin Cancer Res 10:124–130

    Article  PubMed  CAS  Google Scholar 

  5. Kawajiri K, Nakach IK, Imai K et al (1990) Identification of genetically high risk individuals to lung cancer by DNA polymorphisms of the cytochrome P-450IA1 gene. FEBS Lett 263:131–133

    Article  PubMed  CAS  Google Scholar 

  6. Taioli E, Trachman J, Chen X et al (1995) A CYP1A1 restriction fragment length polymorphism is associated with breast cancer in African-American women. Cancer Res 55:3757–3758

    PubMed  CAS  Google Scholar 

  7. Taioli E, Bradlow HL, Garbers SV et al (1999) Role of estradiol metabolism and CYP1A1 polymorphisms in breast cancer risk. Cancer Detect Prev 23:232–237

    Article  PubMed  CAS  Google Scholar 

  8. Garte S, Gaspari L, Alexandrie AK et al (2001) Metabolic gene polymorphism frequencies in control populations. Cancer Epidemiol Biomarkers Prev 10:1239–1248

    PubMed  CAS  Google Scholar 

  9. Crocitto LE, Feigelson HS, Yu MC et al (1997) A polymorphism in intron 6 of the CYP17 gene. Clin Genet 52:68–69

    Article  PubMed  CAS  Google Scholar 

  10. Carey AH, Waterworth D, Patel K et al (1994) Polycystic ovaries and premature male pattern baldness are associated with one allele of the steroid metabolism gene CYP17. Human Mol Genet 3:1873–1876

    Article  CAS  Google Scholar 

  11. Kristensen VN, Haraldsen EK, Anderson KB et al (1999) CYP17 and breast cancer risk: the polymorphism in the 5 flanking area of the gene does not influence binding to Sp-1. Cancer Res 59:2825–2828

    CAS  Google Scholar 

  12. Hong CC, Thompson HJ, Jiang C et al (2004) Association between the T27C polymorphism in the cytochrome P450c17α gene (CYP17) and risk factors for breast cancer. Breast Cancer Res Treatment 88:217–230

    Article  CAS  Google Scholar 

  13. Ambrosone CB, Moysich KB, Furberg H et al (2003) CYP17 genetic polymorphism, breast cancer and breast cancer risk factors. Breast Cancer Res 5:45–51

    Article  CAS  Google Scholar 

  14. Stuven T, Griese EU, Kroemer HK et al (1996) Rapid detection of CYP2D6 null alleles by long distance-and multiplex-polymerase chain reaction. Pharmacogenetics 6:417–421

    Article  PubMed  CAS  Google Scholar 

  15. Ladona MG, Abildúa RE, Ladero JM et al (1996) CYP2D6 genotypes in Spanish women with breast cancer. Cancer Letters 99:23–28

    Article  PubMed  CAS  Google Scholar 

  16. Osborne CK (1998) Tamoxifen in the treatment of breast cancer. N Engl J Med 339:1609–1618

    Article  PubMed  CAS  Google Scholar 

  17. Egan KM, Cai Q, Shu X et al (2004) Genetic polymorphisms in GSTM1, GSTP1, and GSTT1 and the risk for breast cancer: results from the Shanghai breast cancer study and meta-analysis. Cancer Epidemiol Biomark Prev 13:197–204

    Article  CAS  Google Scholar 

  18. Millikan R, Pittman G, Tse C et al (2000) Glutathione S-transferases M1, T1, and P1 and breast cancer. Cancer Epidemiol Biomark Prev 9:567–573

    CAS  Google Scholar 

  19. Parl FF (2005) Glutathione S-transferase genotypes and cancer risk. Cancer Lett 221:123–129

    Article  PubMed  CAS  Google Scholar 

  20. Forrester LM, Hayes JD, Millis R et al (1990) Expression of glutathione S-transferases and cytochrome P450 in normal and tumor breast tissue. Carcinogenesis 11:2163–2170

    Article  PubMed  CAS  Google Scholar 

  21. Board PG, Coggan M, Johnston et al (1990) Genetic heterogeneity of the human glutathione transferases: a complex of gene families. Pharmacol Therap 48:357–369

    Article  CAS  Google Scholar 

  22. Mitrunen K, Jourenkova N, Kataja V et al (2001) Glutathione S-transferase M1, M3, P1, and T1 genetic polymorphisms and susceptibility to breast cancer. Cancer Epidemiol Biomark Prev 10:229–236

    CAS  Google Scholar 

  23. Miller SA, Dykes DD, Polesky HF (1988) A simple salting out procedure for extraction DNA from human nucleated cell. Nucleic Acid Res 16:1215

    Article  PubMed  CAS  Google Scholar 

  24. Carstensen U, Alexandrie AK, Högstedt B et al (1993) B-and T-lymphocyte micronulei in chimney sweeps with respect to genetic polymorphism for CYP1A1 and GST1 (class Mu). Mut Res 289:187–195

    CAS  Google Scholar 

  25. McKean-Cowdin R, Feigelson HS, Pike MC et al (2001) Risk of endometrial cancer and estrogen replacement therapy history by CYP17 genotype. Cancer Res 61:848–849

    PubMed  CAS  Google Scholar 

  26. Sobit RC, Al-Badran AI, Sharma SK et al (2005) Genetics polymorphisms of CYP2D6, GSTM1, and GSTT1 genes and bladder cancer risk in North India. Cancer Genet Cytogenet 156:68–73

    Article  CAS  Google Scholar 

  27. Abdel-Rahman SZ, El-Zein RA, Anwar WA et al (1996) A multiplex PCR procedure for polymorphic analysis of GSTM1 and GSTT1 genes in population studies. Cancer Lett 107:229–233

    Article  PubMed  CAS  Google Scholar 

  28. Harries LW, Stubbins MJ, Forman D et al (1997) Identification of genetic polymorphisms at glutathione S-transferases Pi locus and association with susceptibility to bladder, testicular and prostate cancer. Carcinogenesis 18:641–644

    Article  PubMed  CAS  Google Scholar 

  29. Miller MP (1997) RXC: a program for the analysis of contingency tables. Department of Biological Sciences, Northern Arizona University. Free program distributed by the authors over the internet from the RxC Home Page at http://herb.bio.nau.edu/miller/rxc.htm

  30. Park SK, Kang D, Noh DY et al (2003) Reproductive factors, glutathione S-transferase M1 and T1 genetic polymorphism and breast cancer risk. Breast Cancer Res Treat 78:89–96

    Article  PubMed  CAS  Google Scholar 

  31. Collins JA, Blake JM, Crosignani PG (2005) Breast cancer risk with postmenopausal hormonal treatment. Human Reprod Update 11:545–560

    Article  CAS  Google Scholar 

  32. Van Der Hel OL, Bueno-De-Mesquita HB, Van Gils CH et al (2005) Cumulative genetic defects in carcinogen metabolism may increase breast cancer risk. Cancer Causes Control 16:675–681

    Article  PubMed  Google Scholar 

  33. Amorim LMF, Rossini A, Mendonça G et al (2002) CYP1A1, GSTM1 ad GSTT1 polymorphisms and breast cancer risk in Brazilian woman. Cancer Lett 181:179–186.

    Article  Google Scholar 

  34. Huang CS, Shen CY, Chang KJ et al (1999) Cytochrome P4501A1 polymorphism as a susceptibility factor for breast cancer in postmenopausal Chinese women in Taiwan. Br J Cancer 80:1838–1843

    Article  PubMed  CAS  Google Scholar 

  35. Bergman-Jungestrom M, Gentile M, Lundin AC and the SouthEast Breast Cancer Group (1999) Association between CYP17 gene polymorphism and risk of breast cancer in young women. Int J Cancer 84:350–353

    Article  PubMed  CAS  Google Scholar 

  36. Charrier J, Maugard CM, Le Mevel B, Bignon YJ (1999) Allelotype influence at glutathione S-transferase M1 locus on breast cancer susceptibility. Br J Cancer 79:346–353

    Article  PubMed  CAS  Google Scholar 

  37. Park SK, Yoo KY, Lee SJ et al (2000) Alcohol consumption, glutathione S-transferase M1 and T1 genetic polymorphisms and breast cancer risk. Pharmacogenetics 10:301–309

    Article  PubMed  CAS  Google Scholar 

  38. Roodi N, Dupont WD, Moore JH, Parl FF (2004) Association of homozygous wild-type glutathione S-transferase M1 genotype with increased breast cancer risk. Cancer Res 64:1233–1236

    Article  PubMed  CAS  Google Scholar 

  39. Matheson MC, Stevenson T, Akbarzadeh S, Propert DN (2002) GSTT1 null genotype increases risk of premenopausal breast cancer. Cancer Lett 181:73–79

    Article  PubMed  CAS  Google Scholar 

  40. Hunter DJ, Spielgeman D, Adami HO et al (1997) Non-dietary factors as risk factors for breast cancer and as effect modifiers of the association of fat intake and risk of breast cancer. Cancer Causes Control 8:49–56

    Article  PubMed  CAS  Google Scholar 

  41. Collaborative group of hormonal factors in breast cancer (1996) Breast cancer and hormonal contraceptives: collaborative reanalysis of individual data on 53,297 women with breast cancer and 100,239 women without breast cancer from 54 epidemiological studies. Lancet 347:1713–1727

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Laboratório de Citogenética Humana e Oncogenética, Departamento de Genética, Universidade Federal do Paraná, Caixa Postal 19071, CEP 81531-970, Curitiba, Paraná, Brazil

    C. Torresan, M. M. C. Oliveira, G. T. Torrezan, S. F. V. de Oliveira, C. S. Abuázar, R. Losi-Guembarovski, I. J. Cavalli & E. M. S. F. Ribeiro

  2. Serviço de Oncologia Cirúrgica, Hospital Nossa Senhora das Graças, Curitiba, PR, Brazil

    R. S. Lima & C. A. Urban

Authors
  1. C. Torresan
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M. M. C. Oliveira
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. G. T. Torrezan
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. S. F. V. de Oliveira
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. C. S. Abuázar
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. R. Losi-Guembarovski
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. R. S. Lima
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. C. A. Urban
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. I. J. Cavalli
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. E. M. S. F. Ribeiro
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to E. M. S. F. Ribeiro.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Torresan, C., Oliveira, M.M.C., Torrezan, G.T. et al. Genetic polymorphisms in oestrogen metabolic pathway and breast cancer: a positive association with combined CYP/GST genotypes. Clin. Exper.Med. 8, 65–71 (2008). https://doi.org/10.1007/s10238-008-0159-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10238-008-0159-x

Keywords

Search

Navigation